In 2018, WHO statistics indicated that roughly 7% of the American adults have depression. This figure is arguably the highest in the first world countries and the number initiated one of the most prolonged and intense debates in the recent past. Neurocore has been on a journey to reduce this high percentage by offering one of the best and personalized treatments for depression. The reason why this type of mental disorder is hard to treat using mainstream approaches is that it has many subsections or depressions, which in return complicates a general approach to treatment. Fortunately, this organization has been on a journey to prove that treating all types of depressions is not farfetched. Visit Patch.com to know more about Neurocore.
The organization is one of the first organization to use brainwave-mapping technology. Unlike other methods of treating depressions, this technology does not use any medication, and according to pundits, this has become the trademark of Neurocore. The brainwave-mapping technology capitalizes on the brain capacity, which in return brings a self-healing capability. The application of this technology, however, does not replace Neurocore assessments, which according to mental health pundits are impressively efficient. The application of brainwave-mapping technology is done in line with the assessment findings and more importantly, considering the magnitude of the depression. Follow Neurocore on Twitter.
The best part of using this technology is that the expert attending the patient can identify the cause of the depression. The technique exploits all the brain features to rewire the same organ for self-healing. Although this is not the only type of healing, it is one of the Neurocore flagships in the recent past. After going through this treatment procedure, which can take months, patients from this organization have the highest success rates in the overall results. For example, this treatment process has over 84% success in the stress reduction. Although stress is not quantifiable, many patients have a higher percentage of verifiable changes.